Boston, San Francisco, Stockholm – January 12, 2023
Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...
Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...